Krzysztof Białas

Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis

G. Helbig, M. Markiewicz, M. Kopera, 2019, Medical Oncology.

Safety and outcome of allogeneic stem cell transplantation in myelofibrosis

G. Helbig, S. Mizia, S. Kyrcz‐Krzemień, 2016, European journal of haematology.

Early assessment of donor CD34+ positive cells chimerism after allogeneic stem cell transplantation in acute myeloid leukemia/myelodysplastic syndrome patients – pilot study

S. Kyrcz‐Krzemień, M. Dzierżak-Mietła, A. Koclęga, 2016 .

Assessment of lineage-specific chimerism after allogeneic stem cell transplantation

S. Kyrcz‐Krzemień, M. Markiewicz, M. Dzierżak-Mietła, 2014 .

Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation

A. Suszka-Świtek, R. Wiaderkiewicz, S. Mizia, 2022, World journal of biological chemistry.

The Influence Of Anti-HLA Antibodies On Engraftment and Donor’s Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

U. Siekiera, S. Mizia, S. Kyrcz‐Krzemień, 2013 .

Proinflammatory cytokines as potential risk factors of acute graft-versus-host disease and infectious complications after allogeneic hematopoietic stem cell transplantation.

A. Suszka-Świtek, R. Wiaderkiewicz, S. Mizia, 2021, American journal of blood research.